Vivo Opportunity Fund Holdings, L.P. - Significant Ownership

Signature - Title
/s/ Kevin Dai - Kevin Dai/Managing Member of Vivo Opportunity, LLC, General Partner
Location
Palo Alto, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Vivo Opportunity Fund Holdings, L.P..

Significant Ownership of Vivo Opportunity Fund Holdings, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
DBVT DBV Technologies S.A. Ordinary shares, nominal value 0.10 euro per share 9.99% $144M 20.4M Vivo Opportunity Fund Holdings, L.P. Apr 7, 2025
SABS SAB Biotherapeutics, Inc. Common Stock, par value $0.0001 per share 9.99% $55M 25.9M Vivo Opportunity Fund Holdings, L.P. Sep 29, 2025
UNCY Unicycive Therapeutics, Inc. Common Stock, $0.001 par value per share 9.99% $32.3M 61M Vivo Opportunity Fund Holdings, L.P. Mar 31, 2025
UNCY Unicycive Therapeutics, Inc. Common Stock, $0.001 par value per share 9.99% $26.6M 6.1M Vivo Opportunity Fund Holdings, L.P. Sep 30, 2025
CAMP Camp4 Therapeutics Corp Common Stock, par value $0.0001 per share 7.6% $7.19M 3.56M Vivo Opportunity Fund Holdings, L.P. Sep 11, 2025
DRUG Bright Minds Biosciences Inc. Common Stock, no par value 6.4% $27.6M 454K Vivo Opportunity Fund Holdings, L.P. Sep 30, 2025
CMPX Compass Therapeutics, Inc. Common Stock, par value $0.0001 per share 5.1% $31.5M 9M Vivo Opportunity Fund Holdings, L.P. Sep 30, 2025
CDTX Cidara Therapeutics, Inc. Common Stock, $0.0001 par value 4.6% $57.3M $27.4M 1.18M +92% Vivo Opportunity Fund Holdings, L.P. Jun 30, 2025
SLNO Soleno Therapeutics, Inc. Common Stock, $0.001 par value per share 4.2% $152M -$115M 2.25M -43.1% Vivo Opportunity Fund Holdings, L.P. Sep 30, 2025
RGLS Regulus Therapeutics Inc. Common Stock, $0.001 par value 3.9% $4.64M 2.7M Vivo Opportunity Fund Holdings, L.P. Mar 31, 2025
CMPS COMPASS Pathways plc Ordinary Shares, par value (pound)0.008 per share, represented by American Depositary Shares 3.2% $18.2M -$18.2M 3.17M -50% Vivo Opportunity Fund Holdings, L.P. Sep 30, 2025
DCTH Delcath Systems, Inc. Common Stock, $0.01 par value per share 2.2% $9M 750K Vivo Opportunity Fund Holdings, L.P. Mar 31, 2025

Schedules 13D/G Reported by Vivo Opportunity Fund Holdings, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.